from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1069c/-

LFCtreatmentdescriptionclass of inhibitor

-0.716

Amikacinug/mL Amikacintranslation

-1.928

Cap5-10ug/mL Capreomycintranslation

-2.076

Rox10-50 ug/mL Roxithromycintranslation

-0.135

SM2-5 ug/mL Streptomycintranslation

-1.163

Tet5-10 ug/mL Tetracyclinetranslation

1.281

Rif0.2-5ug/mL Rifampicintranscription

0.740

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.943

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.704

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.090

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.265

Clofazimine10-13 ug/mL Clofaziminerespiration

0.342

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.289

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.032

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.271

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.156

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.215

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.324

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.402

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.087

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.095

KCN5-20 ug/mL Potassium cyaniderespiration

0.681

NaN30.2-2 mM Sodium aziderespiration

0.168

Nigericin50 uM Nigericinrespiration

0.559

TRC10-150 ug/mL Triclosanrespiration

-0.820

TRZ10-25 ug/mL Thioridazinerespiration

-1.820

Valinomycin0.5-10 uM Valinomycinrespiration

1.162

ZnSO42 mM ZnSO4respiration

-0.215

menadione6-10 ug/mL Menadionerespiration

-0.340

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.467

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.207

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.398

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.328

NRP_1Non-replicating persistence stage 1dosRassociated

-0.279

Amp0.2mg/mL AmpicillincellWall

0.066

Cephalexin20-100 ug/mL CephalexincellWall

0.435

Cerulenin0.32-5 ug/mL CerulenincellWall

0.673

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.212

EMB10-20 ug/mL EthambutolcellWall

0.410

Eta12-40 ug/mL EthionamidecellWall

0.118

INH0.2-0.4 ug/mL IsoniazidcellWall

0.216

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.781

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.413

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.001

BZA0.12 mg/mL BenzamidearomaticAmides

0.389

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.270

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.564

H2O24 mM hydrogen peroxideDNAdamaging

0.307

Levo10 ug/mL LevofloxacinDNAdamaging

0.209

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.343

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.175

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.184

UVUV-irradiationDNAdamaging

-0.309

ARP41-4 ug/mL Antitubercular compound ARP4?

0.783

Antimycin12.5-50 ug/mL Antimycin A?

-0.009

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.113

PA_110-50 ug/mL Antitubercular compound PA-1?

0.500

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.112

PA8240.2-2 ug/mL PA-824?

0.163

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.459

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.391

Verapamil50 uM Verapamil?

-0.449

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.131

methoxatin10-20 ug/mL Methoxatin?